Researchers at Sidney Kimmel Cancer Center at Thomas Jefferson University Promise New Directions for Targeting Prostate Cancer
A team of Sidney Kimmel Cancer Center (SKCC) investigators from Thomas Jefferson University and Drexel University has recently published a new study in the journal Cancer Research that sheds light on a key mechanism of prostate cancer progression. The research was performed as a collaborative effort involving two SKCC investigators, Dr. Felix J. Kim of the Department of Pharmacology & Physiology at Drexel University and lead author of the study, and Dr. Karen E. Knudsen, Director of SKCC and Chair of Cancer Biology at Thomas Jefferson University, together with a third investigator, Dr. Joseph M. Salvino of the Wistar Institute. Drs. Kim and Knudsen are members of the SKCC Program of Excellence in Prostate Cancer, one of only eight such prestigious NCI-designated prostate cancer research and treatment programs.
